Metastatic pancreatic cancer: Is there a light at the end of the tunnel?

Due to extremely poor prognosis, pancreatic cancer (PDAC) represents the fourth leading cause of cancer-related death in Western countries. For more than a decade, gemcitabine (Gem) has been the mainstay of first-line PDAC treatment. Many efforts aimed at improving single-agent Gem efficacy by eithe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:World J Gastroenterol
Auteurs principaux: Vaccaro, Vanja, Sperduti, Isabella, Vari, Sabrina, Bria, Emilio, Melisi, Davide, Garufi, Carlo, Nuzzo, Carmen, Scarpa, Aldo, Tortora, Giampaolo, Cognetti, Francesco, Reni, Michele, Milella, Michele
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Inc 2015
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4408451/
https://ncbi.nlm.nih.gov/pubmed/25944992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i16.4788
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires